Document is current
Any future updates will be listed below
-
Authors
Sakaue, Saori https://orcid.org/0000-0003-3618-9717
,
Anolik, Jennifer H.
Apruzzese, William
Arazi, Arnon
Barnas, Jennifer L.
Belmont, H. Michael
Berthier, Celine C.
Buyon, Jill P.
Curtis, Michelle
Cuda, Carla M.
Dall’Era, Maria
Davidson, Anne
Diamond, Betty
Eisenhaure, Thomas M.
Fava, Andrea
Grossman, Jennifer
Gurajala, Siddarth
Guthridge, Joel M.
Hacohen, Nir
Hildeman, David A.
Hodgin, Jeffrey B.
Hoover, Paul J.
Horsberger, Alice
Izmirly, Peter M.
James, Judith A.
Kalunian, Kenneth C.
Kamen, Diane L.
Mears, Joseph
McMahon, Maureen A.
Peters, Michael
Petri, Michelle A.
Perlman, Harris
Putterman, Chaim
Rao, Deepak A.
Raychowdhury, Raktima
Rovin, Brad
Payan-Schober, Fernanda
Sugiarto, Nicholas W.
Wofsy, David
Woodle, E. Steve
Xiao, Qian
Zhao, Yu
Raychaudhuri, Soumya https://orcid.org/0000-0002-1901-8265
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01AR063759)
U.S. Department of Health & Human Services | National Institutes of Health (U01HG012009)
U.S. Department of Health & Human Services | National Institutes of Health (UC2AR081023)
- License Information
-
More Information
Article History
Received: 26 March 2025
Accepted: 3 April 2026
First Online: 25 April 2026
Competing interests
: S.R. is a founder of Mestag, Inc, a scientific advisor for Jannsen and Pfizer, and serves as a consultant for Sanofi, AbbVie, Nimbus, and Third Rock Ventures. S.S. declares no competing interests.
